Schoenfeld Andrew J, Holly Kaitlyn E, Bryan Matthew R, Hatton Malina O, Wien Matthew, Koehlmoos Tracey P
Center for Surgery and Public Health, Department of Orthopaedic Surgery, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA, 02115, USA.
Department of Orthopaedic Surgery, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA, 02115, USA.
Lancet Reg Health Am. 2025 Apr 18;46:101108. doi: 10.1016/j.lana.2025.101108. eCollection 2025 Jun.
Research has shown that multiple deployments may have adverse effects on active-duty servicewomen and women civilian dependents of active-duty servicemembers. There is concern that the associated stress could induce sustained prescription opioid use and substance use disorder (SUD). We sought to evaluate the incidence of sustained opioid use and SUD among servicewomen and women civilian dependents during 2006-2013, a period of increased operational intensity, compared to similar individuals in 2014-2022.
We employed Military Health System claims data to identify servicewomen and dependents who were diagnosed with SUD or demonstrated sustained prescription opioid use (i.e., six months of uninterrupted use). The incidence of sustained opioid use (primary outcome) and SUD associated (secondary outcome) with 2006-2013 was compared to 2014-2022 among servicewomen and dependents. Multivariable log binomial regression was used to adjust for confounding. Ethnicity was not available in our dataset.
4,876,209 individuals were included. The average age (standard deviation [SD]) of the cohorts under study were 26.6 (SD 8.2) for active duty 2006-2013, 26.0 (SD 8.0) for active duty 2014-2022, 35.3 (SD 13.1) for dependents 2006-2013 and 33.6 (SD 12.1) for dependents 2014-2022. Compared to civilian dependents in 2014-2022, servicewomen from 2006 to 2013 demonstrated an increased risk of sustained prescription opioid use (RR 1.49, 95% CI 1.46-1.53). In 2014-2022, servicewomen had a lower risk compared to dependents (RR 0.47, 95% CI 0.45-0.49), while dependents in 2006-2013 were also at higher risk (RR 1.58, 95% CI 1.56-1.60). Servicewomen in 2006-2013 were at significantly greater risk of developing SUD (RR 1.07, 95% CI 1.06-1.08). During 2014-2022, servicewomen displayed a lower risk when compared to dependents (RR 0.80, 95% CI 0.79-0.81). Dependents in 2006-2013 showed a higher risk (RR 1.24, 95% CI 1.24-1.25).
We found significant increases in the risks of sustained opioid use and SUD among servicewomen and civilian dependents during a period of increased operational intensity (2006-2013). We believe these findings reflect the deleterious effects of emotional stress, insufficient support structures, and military sexual trauma.
U.S. Department of Defense, Defense Health Agency (#HU00012320021).
研究表明,多次部署可能会对现役女军人以及现役军人的女性家属产生不利影响。人们担心相关压力可能导致持续使用处方阿片类药物以及物质使用障碍(SUD)。我们试图评估2006年至2013年期间(这是一个行动强度增加的时期),与2014年至2022年期间的类似个体相比,女军人和女性家属中持续使用阿片类药物和物质使用障碍的发生率。
我们利用军事卫生系统的索赔数据来识别被诊断为物质使用障碍或表现出持续使用处方阿片类药物(即连续使用六个月)的女军人和家属。将2006年至2013年期间女军人和家属中持续使用阿片类药物(主要结局)和物质使用障碍相关(次要结局)的发生率与2014年至2022年期间进行比较。使用多变量对数二项回归来调整混杂因素。我们的数据集中没有种族信息。
共纳入4,876,209人。所研究队列的平均年龄(标准差[SD])分别为:2006年至2013年现役军人26.6岁(SD 8.2),2014年至2022年现役军人26.0岁(SD 8.0),2006年至2013年家属35.3岁(SD 13.1),2014年至2022年家属33.6岁(SD 12.1)。与2014年至2022年的平民家属相比,2006年至2013年的女军人持续使用处方阿片类药物的风险增加(风险比[RR] 1.49,95%置信区间[CI] 1.46 - 1.53)。在2014年至2022年,女军人的风险低于家属(RR 0.47,95% CI 0.45 - 0.49),而2006年至2013年的家属风险也更高(RR 1.58,95% CI 1.56 - 1.60)。2006年至2013年的女军人患物质使用障碍的风险显著更高(RR 1.07,95% CI 1.06 - 1.08)。在2014年至2022年期间,女军人与家属相比风险较低(RR 0.80,95% CI 0.79 - 0.81)。2006年至2013年的家属风险较高(RR 1.24,95% CI 1.24 - 1.25)。
我们发现,在行动强度增加的时期(2006年至2013年),女军人和平民家属中持续使用阿片类药物和物质使用障碍的风险显著增加。我们认为这些发现反映了情绪压力、支持结构不足以及军事性创伤的有害影响。
美国国防部国防卫生局(#HU00012320021)。